📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Pin Therapeutics

1.1 - Company Overview

Pin Therapeutics Logo

Pin Therapeutics

Headquarter: South Korea
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of advanced protein degradation therapeutics, utilizing biological pathways of proteostasis to develop therapeutics.

Products and services

  • Proteostasis Pathway–Based Therapeutic Development: Develops therapeutics leveraging biological pathways of proteostasis to enable advanced protein degradation
  • Pathway-centric approach structures design around proteostasis-driven mechanisms
  • Proteostasis-Guided Degradation Therapies: Architects therapeutics focused on advanced protein degradation by harnessing proteostasis biological pathways
  • Mechanism-driven framework integrates proteostasis knowledge directly into therapeutic development
  • Advanced Protein Degradation Therapeutics: Constructs therapeutics by utilizing biological pathways of proteostasis to promote protein degradation
  • Custom-engineered methodology aligns development with proteostasis-based mechanisms for therapeutic efficacy

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Pin Therapeutics

Senda Biosciences Logo

Senda Biosciences

HQ: United States Website
  • Description: Provider of a therapeutics platform leveraging insights into molecular connections between humans, offering Endless RNA (eRNA) to program proteins inside the body with long-lasting expression, Natural NanoParticle (NNP) technology with nanoparticles derived from nature for targeted delivery of biomolecules into human cells, and AI-driven integrative design of RNA medicines for oncology and rare diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Senda Biosciences company profile →
Navamedic Logo

Navamedic

HQ: Sweden Website
  • Description: Provider of pharmaceutical and medtech products, marketing to patients, hospitals and pharmacies. Offers prescription and OTC medicines and healthcare products; the Sippi next-generation digital urine meter; and a portfolio including Eroxon gel to help men achieve an erection, Flexilev for Parkinson’s, Absolut Torr antiperspirant, MedMade micronutrient supplements, and PKU and obesity education/support programs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Navamedic company profile →
AstraZeneca Logo

AstraZeneca

HQ: United Kingdom Website
  • Description: Provider of biopharmaceutical research, development, manufacturing, and marketing of prescription medicines across oncology; cardiovascular, renal and metabolism; respiratory and immunology; vaccines and immune therapies; and rare diseases. Portfolio includes therapies such as datopotamab deruxtecan for advanced nonsquamous non-small cell lung cancer, with clinical trial survival benefits.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AstraZeneca company profile →
Palatin Technologies Logo

Palatin Technologies

HQ: United States Website
  • Description: Provider of targeted receptor-specific peptide therapeutics, including Vyleesi (bremelanotide injection) for premenopausal women with HSDD, and a pipeline of melanocortin-based candidates: PL9643 (Phase 3) for dry eye disease; PL9654 for ocular diseases (IVT and topical); PL8177 (oral, Phase 2) for ulcerative colitis; bremelanotide + PDE5i (Phase 2) for sexual dysfunction; and a planned MCR4 agonist program for obesity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Palatin Technologies company profile →
Merck Logo

Merck

HQ: Germany Website
  • Description: Provider of life science, healthcare, and electronics solutions in the U.S. and Canada as EMD Serono, MilliporeSigma, and EMD Electronics. Supplies lab chemicals, solvents, materials, and tools; process solutions for drug development; end-to-end testing, analytics, and manufacturing support; develops medicines and devices for cancer, multiple sclerosis, fertility, and endocrine disorders; and materials/equipment for semiconductors, displays, and surfaces.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Merck company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Pin Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Pin Therapeutics

2.2 - Growth funds investing in similar companies to Pin Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Pin Therapeutics

4.2 - Public trading comparable groups for Pin Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Pin Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Pin Therapeutics

What does Pin Therapeutics do?

Pin Therapeutics is a provider of advanced protein degradation therapeutics, utilizing biological pathways of proteostasis to develop therapeutics.

Who are Pin Therapeutics's competitors?

Pin Therapeutics's competitors and similar companies include Senda Biosciences, Navamedic, AstraZeneca, Palatin Technologies, and Merck.

Where is Pin Therapeutics headquartered?

Pin Therapeutics is headquartered in South Korea.

How many employees does Pin Therapeutics have?

Pin Therapeutics has 1,000 employees 🔒.

When was Pin Therapeutics founded?

Pin Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Pin Therapeutics in?

Pin Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Pin Therapeutics

Who are the top strategic acquirers in Pin Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Pin Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Pin Therapeutics?

Top strategic M&A buyers groups and sectors for Pin Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Pin Therapeutics's sector and industry vertical

Which are the top PE firms investing in Pin Therapeutics's sector and industry vertical?

Top PE firms investing in Pin Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Pin Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Pin Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Pin Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Pin Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Pin Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Pin Therapeutics?

The key public trading comparables and valuation benchmarks for Pin Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Pin Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Pin Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Pin Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Pin Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Pin Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Pin Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Pin Therapeutics

Launch login modal Launch register modal